Literature DB >> 3572807

Skin absorption and cutaneous first pass metabolism of topical steroids: in vitro studies with mouse skin in organ culture.

J Kao, J Hall.   

Abstract

Using mouse skin maintained in a permeability chamber-organ culture system, we have examined the percutaneous penetration and cutaneous fate of some selected steroids. At 16 hr after in vitro topical application (10 micrograms/2 cm2), the extent of permeation of the selected steroids was testosterone (65.13%) much greater than cortisol (18.1%) = estradiol (18.0%) greater than estrone (10.58%) much greater than estriol (2.45%). Permeation was accompanied by cutaneous first pass metabolism. In addition to water-soluble metabolites, other metabolites found in the perfusion medium from topical testosterone included 5 alpha-dihydrotestosterone, 5 alpha-androstanedione and androstenedione. Cortisone was identified as one of the metabolites of topical cortisol. For the estrogens, estradiol and estriol were metabolites of topical estrone, whereas estrone and estriol were metabolites of topical estradiol. The extent of cutaneous first pass metabolism of these selected steroids varies considerably. Estrone was metabolized extensively, but only limited metabolism of estradiol and cortisol was observed during their translocation through the skin. With testosterone, it was evident that an increase in the topically applied dose was accompanied by a decrease in the relative extent of both permeation and cutaneous first pass metabolism. However, cutaneous first pass metabolism of estriol was essentially negligible. These observations demonstrated that both diffusional and metabolic processes are important in the percutaneous fate of topical steroids. They also suggest that in future studies concerned with the absorption and bioavailability of topically applied chemicals, an assessment of the drug-metabolizing capabilities of the skin needs to be considered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572807

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

2.  Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results.

Authors:  D B Guzek; A H Kennedy; S C McNeill; E Wakshull; R O Potts
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

3.  Transdermal drug transport and metabolism. II. The role of competing kinetic events.

Authors:  R O Potts; S C McNeill; C R Desbonnet; E Wakshull
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

4.  In vivo absorption of steroidal hormones from smart polymer based delivery systems.

Authors:  Sibao Chen; Daniel Pederson; Mayura Oak; Jagdish Singh
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

5.  Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.

Authors:  S Ahmed; T Imai; M Otagiri
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

6.  Prediction of the percutaneous penetration and metabolism of dodecyl decaethoxylate in rats using in vitro models.

Authors:  C S Roper; D Howes; P G Blain; F M Williams
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

7.  Biotransformation of estradiol in the human keratinocyte cell line HaCaT: metabolism kinetics and the inhibitory effect of ethanol.

Authors:  R Altenburger; T Kissel
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

8.  Fate of fluazifop butyl in rat and human skin in vitro.

Authors:  N W Clark; R C Scott; P G Blain; F M Williams
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.